WASHINGTON — The Food and Drug Administration said Monday it is doing away with a longstanding warning label on hormone replacement therapy for women. Since 2003, the FDA has required the makers of popular drugs that treat menopause symptoms to include labeling that warns of the risks of cardiovascular disease, breast cancer and dementia.

“We are challenging outdated thinking and recommitting to evidence-based medicine that empowers rather than restricts,” Health and Human Services Secretary Robert F. Kennedy Jr. said during a news conference. “When prescribed responsibly and started early, hormone replacement therapy transforms the lives of women.”

According to WebMD.com, menopause symptoms include fatigue, depression, crankiness, headaches, weight gain, hair loss, changes in libido, lo

See Full Page